AAAAAA
Results: 51-70/70
Authors:
Gilmour, E
Bhushan, M
Griffiths, CEM
Citation: E. Gilmour et al., Figurate erythema with bullous pemphigoid: a true paraneoplastic phenomenon?, CLIN EXP D, 24(6), 1999, pp. 446-448
Authors:
Lyon, CC
Griffiths, CEM
Citation: Cc. Lyon et Cem. Griffiths, Chronic granulomatous disease and acute neutrophilic dermatosis, CLIN EXP D, 24(5), 1999, pp. 368-371
Authors:
Griffiths, CEM
Citation: Cem. Griffiths, Dowling Oration delivered at the Royal College of Physicians, London, Friday 5 June 1998. Retinoids: renaissance and reformation, CLIN EXP D, 24(4), 1999, pp. 329-335
Authors:
Richards, HL
Fortune, DG
O'Sullivan, TM
Main, CJ
Griffiths, CEM
Citation: Hl. Richards et al., Patients with psoriasis and their compliance with medication, J AM ACAD D, 41(4), 1999, pp. 581-583
Authors:
Fortune, DG
Richards, HL
Bowcock, S
Main, CJ
Griffiths, CEM
Citation: Dg. Fortune et al., What patients with psoriasis believe about their condition - Reply, J AM ACAD D, 41(2), 1999, pp. 283-284
Authors:
Watson, REB
Griffiths, CEM
Craven, NM
Shuttleworth, CA
Kielty, CM
Citation: Reb. Watson et al., Fibrillin-rich microfibrils are reduced in photoaged skin. Distribution atthe dermal-epidermal junction, J INVES DER, 112(5), 1999, pp. 782-787
Authors:
Bhushan, M
McLaughlin, B
Weiss, JB
Griffiths, CEM
Citation: M. Bhushan et al., Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis, BR J DERM, 141(6), 1999, pp. 1054-1060
Authors:
Griffiths, CEM
Citation: Cem. Griffiths, The British Association of Dermatologists guidelines for the management ofskin disease, BR J DERM, 141(3), 1999, pp. 396-397
Clinical measures of disease severity and outcome in psoriasis: a criticalappraisal of their quality
Authors:
Ashcroft, DM
Po, ALW
Williams, HC
Griffiths, CEM
Citation: Dm. Ashcroft et al., Clinical measures of disease severity and outcome in psoriasis: a criticalappraisal of their quality, BR J DERM, 141(2), 1999, pp. 185-191
Authors:
Cumberbatch, M
Griffiths, CEM
Tucker, SC
Dearman, RJ
Kimber, I
Citation: M. Cumberbatch et al., Tumour necrosis factor-alpha induces Langerhans cell migration in humans, BR J DERM, 141(2), 1999, pp. 192-200
Authors:
Clark, CM
Kirby, B
Morris, AD
Davison, S
Zaki, I
Emerson, R
Saihan, EM
Chalmers, RJG
Barker, JNWN
Allen, BR
Griffiths, CEM
Citation: Cm. Clark et al., Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis, BR J DERM, 141(2), 1999, pp. 279-282
Authors:
Ho, VC
Griffiths, CEM
Albrecht, G
Vanaclocha, F
Leon-Dorantes, G
Atakan, N
Reitamo, S
Johannesson, A
Mork, NJ
Clarke, P
Pfister, P
Paul, C
Citation: Vc. Ho et al., Intermittent short courses of cyclosporin (Neoral (R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study, BR J DERM, 141(2), 1999, pp. 283-291
Authors:
Lyon, CC
Kirby, B
Griffiths, CEM
Citation: Cc. Lyon et al., Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus, BR J DERM, 140(3), 1999, pp. 562-564
Authors:
Griffiths, CEM
Citation: Cem. Griffiths, Novel therapeutic approaches to psoriasis, HOSP MED, 59(7), 1998, pp. 539-542
Authors:
Griffiths, CEM
Citation: Cem. Griffiths, Retinoids and vitamin D analogues: action on nuclear transcription, HOSP MED, 59(1), 1998, pp. 12-16
Authors:
Clark, CM
Mckay, RA
Fortune, DG
Griffiths, CEM
Citation: Cm. Clark et al., Use of alternative treatments by patients with psoriasis, BR J GEN PR, 48(437), 1998, pp. 1873-1874
Authors:
Griffiths, CEM
Citation: Cem. Griffiths, Up-grading the grading of acne, J DERM TR, 9(4), 1998, pp. 209-209
Authors:
Ashcroft, DM
Po, ALW
Williams, HC
Griffiths, CEM
Citation: Dm. Ashcroft et al., Quality of life measures in psoriasis: a critical appraisal of their quality, J CLIN PH T, 23(5), 1998, pp. 391-398
Authors:
Bhushan, M
McElhone, K
Griffiths, CEM
Citation: M. Bhushan et al., GMDP and psoriasis, LANCET, 352(9143), 1998, pp. 1857-1857
Authors:
Rivier, M
Safonova, I
Lebrun, P
Griffiths, CEM
Ailhaud, G
Michel, S
Citation: M. Rivier et al., Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes, J INVES DER, 111(6), 1998, pp. 1116-1121